An update on assessment and treatment of complex attention-deficit hyperactivity disorder

Pediatric Annals

Volumn 30, Issue 3, 2001, Pages 162-172

  Hunt, R D ^a   Paguin, A ^a   Payton, K ^a  

^a Ctr Attention Hyperactivity Disord   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMPHETAMINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CITALOPRAM; CLONIDINE; DESIPRAMINE; DEXAMPHETAMINE; FLUOXETINE; FLUVOXAMINE; GUANFACINE; IMIPRAMINE; LITHIUM; METHYLPHENIDATE; MIRTAZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PSYCHOSTIMULANT AGENT; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VALPROIC ACID; VENLAFAXINE;

AGGRESSION; ANOREXIA; ATTENTION DEFICIT DISORDER; CARDIOTOXICITY; CLINICAL EXAMINATION; CLINICAL TRIAL; DROWSINESS; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; HEADACHE; HUMAN; INSOMNIA; MOOD; PSYCHODYNAMICS; PSYCHOLOGIC ASSESSMENT; REVIEW; SEXUAL DYSFUNCTION; STOMACH PAIN;

EID: 0035102893     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-20010301-10     Document Type: Review

References (47)

1. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: An overview
2. Latent class and factor analysis of DSM-IV ADHD: A twin study of female adolescents
3. Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study
4. Normalized functioning in youths with persistent attention-deficit/hyperactivity disorder
5. Adolescents with ADHD: Patterns of behavioral adjustment, academic functioning, and treatment utilization
6. The relationship of attention deficit hyperactivity disorder and conduct disorder to juvenile delinquency: Legal implications
7. Diagnosing attention-deficit/hyperactivity disorder in children
8. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder
9. Attention-deficit/hyperactivity disorder: A life-span perspective
10. Problems in the management of attention-deficit-hyperactivity disorder
11. Gender differences in ADHD: A meta-analysis and critical review
12. Developmental change in attention-deficit hyperactivity disorder in boys: A four-year longitudinal study
13. The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study
14. Persistence of hyperactivity symptoms from childhood to adolescence and associated outcomes
15. Psychiatric status of hyperactives as adults: A controlled prospective 15-year follow-up of 63 hyperactive children
16. A twin study of hyperactivity: II. The aetiological role of genes, family relationships and perinatal adversity
17. Genetic influence on parent-reported attention-related problems in a Norwegian general population twin sample
18. Attention-deficit hyperactivity disorder: A category or a continuum? Genetic analysis of a large-scale twin study
19. Attention-deficit hyperactivity disorder dimensions: A twin study of inattention and impulsivity-hyperactivity
20. Attention deficithyperactivity disorder in people with generalized resistance to thyroid hormone
21. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism
22. Attention deficit-hyperactivity disorder and asymmetry of the caudate nucleus
23. Basal ganglia volumes in children with attention-deficit hyperactivity disorder
24. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder
25. Evaluation of cerebellar size in attention-deficit hyperactivity disorder
26. Cerebellum in attention-deficit hyperactivity disorder: A morphometric MRI study
27. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents: Council on Scientific Affairs, American Medical Association
28. Comparison of diagnostic criteria for attention deficit disorders in a German elementary school sample
29. Validity of the age of onset criterion for ADHD: A report from the DSM-IV field trials
30. Parents Of children with attention-deficit/hyperactivity disorder: Psychological and attentional impairment
31. Treatment of attention-deficit hyperactivity disorder
32. Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder
33. National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA): Design challenges and choices
34. MTA results
35. Pharmacotherapy of attention-deficit disorder across the life cycle
36. Psychopharmacology of ADHD: Children and adolescents
37. A comparison of Ritalin and Adderall: Efficacy and time-course in children with attention-deficit/hyperactivity disorder
38. Comparing Adderall and methylphenidate in ADHD
39. Acute tolerance to methylphenidate in the treatment of attention deficit hyperactive disorder in children
40. Treatment preference comparison of Concerta, MPH t.i.d., and placebo in children with ADHD
41. Long-term safety and effectiveness of Concerta in children with ADHD
42. Current drug therapy recommendations for the treatment of attention deficit hyperactivity disorder
43. Possible change in noradrenergic receptor sensitivity following methylphenidate treatment: Growth hormone and MHPG response to clonidine challenge in children with attention deficit disorder and hyperactivity
44. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder